Scarica l'app Stockscreener
0.8369
3.02%
0.0245
Precedente Chiudi:
$0.8124
Aprire:
$0.8
Volume 24 ore:
180.69K
Relative Volume:
0.59
Capitalizzazione di mercato:
$46.34M
Reddito:
$3.10M
Utile/perdita netta:
$-97.43M
Rapporto P/E:
-0.377
EPS:
-2.22
Flusso di cassa netto:
$-94.38M
1 W Prestazione:
-13.63%
1M Prestazione:
+5.91%
6M Prestazione:
-61.96%
1 anno Prestazione:
-62.80%
Intervallo 1D:
$0.7924
$0.88
Intervallo di 1 settimana:
$0.782
$0.98
Portata 52W:
$0.75
$6.30
Omega Therapeutics Inc Stock (OMGA) Company Profile
Nome
Omega Therapeutics Inc
Settore
Industria
Telefono
(617) 949-4360
Indirizzo
140 FIRST STREET, SUITE 501, CAMBRIDGE
Confronta OMGA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OMGA
Omega Therapeutics Inc
|
0.8369 | 46.34M | 3.10M | -97.43M | -94.38M | -1.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Omega Therapeutics Inc Stock (OMGA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-06-18 | Iniziato | Raymond James | Outperform |
| 2023-05-25 | Ripresa | Jefferies | Buy |
| 2022-12-08 | Iniziato | H.C. Wainwright | Buy |
| 2022-09-23 | Iniziato | Chardan Capital Markets | Buy |
Omega Therapeutics Inc Borsa (OMGA) Ultime notizie
Layoff Tracker: Editas Will Cut 60% of Staff - BioSpace
Omega Therapeutics, Inc. Announces Board and Committee Changes - Marketscreener.com
Omega Therapeutics announces board changes By Investing.com - Investing.com Nigeria
Omega Therapeutics announces board changes - Investing.com India
Omega Therapeutics Appoints New Director Ravi Mehrotra - TipRanks
2024’s Busiest Dealmakers: Novartis Laps The Field, While Lilly, Sanofi Keep Busy - Citeline News & Insights
Omega Therapeutics, Inc. (OMGA) Reports Q3 Loss, Tops Revenue Estimates - MSN
Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies - Quantisnow
Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer – Company Announcement - Financial Times
Piper Sandler Lowers Omega Therapeutics (NASDAQ:OMGA) Price Target to $4.00 - Defense World
Omega Therapeutics Reports Third Quarter 2024 Results - TipRanks
Omega Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line - Yahoo Finance
Omega Therapeutics stock target cut, keeps Overweight on clinical updates By Investing.com - Investing.com Canada
Shares of Flagship-founded biotech fall as CEO departs - The Business Journals
Omega Therapeutics (NASDAQ:OMGA) Downgraded to Market Perform Rating by Raymond James - MarketBeat
Piper Sandler Issues Pessimistic Forecast for Omega Therapeutics (NASDAQ:OMGA) Stock Price - MarketBeat
Omega Therapeutics Inc (OMGA) Quarterly 10-Q Report - Quartzy
Omega Therapeutics Names Kaan Certel as CEO - MarketWatch
Omega Therapeutics Announces Successful Completion of Phase - GlobeNewswire
Omega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial Results - The Manila Times
Omega Therapeutics, Inc. Announces Chief Executive Officer Changes - Marketscreener.com
Brian M. Alexander Joins Valo Health as Chief Executive Officer and Flagship Pioneering as CEO-Partner - Financial Times
Omega Therapeutics (NASDAQ:OMGA) Stock Price Down 0.9%Should You Sell? - MarketBeat
Global Alopecia Treatment Market is Anticipated to Surpass ~USD 4 Billion by 2030 | DelveInsight - GlobeNewswire
Oculis Holding AG (OCS) Moves 7.9% Higher: Will This Strength Last? - Yahoo Finance
Pre-market Movers: EVOK, HCTI, GLUE, MNPR... - RTTNews
State Street Corp's Strategic Acquisition in Omega Healthcare Investors Inc - Yahoo Finance
Zura Bio (NASDAQ:ZURA) versus Omega Therapeutics (NASDAQ:OMGA) Critical Contrast - Defense World
Omega Therapeutics stock hits 52-week low at $0.94 By Investing.com - Investing.com Australia
Cubist Systematic Strategies LLC Grows Holdings in Omega Therapeutics, Inc. (NASDAQ:OMGA) - Defense World
Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings - The Manila Times
Omega Therapeutics to Present Multiple Posters Highlighting - GlobeNewswire
Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions - Financial Times
Omega Therapeutics stock hits 52-week low at $1.07 By Investing.com - Investing.com Australia
Omega Therapeutics stock hits 52-week low at $1.07 - Investing.com India
Omega Therapeutics Appoints New Director - Investing.com India
Omega Therapeutics Welcomes Robert Rosiello to Board - TipRanks
Omega Therapeutics Inc Azioni (OMGA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):